SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001659617-19-000069
Filing Date
2019-05-13
Accepted
2019-05-13 16:02:26
Documents
55
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mbx-20190331.htm   iXBRL 10-Q 970118
2 EXHIBIT 31.1 a2019q1ex311-xnextgen.htm EX-31.1 11657
3 EXHIBIT 31.2 a2019q1ex312-xnextgen.htm EX-31.2 11358
4 EXHIBIT 32.1 a2019q1ex321-xnextgen.htm EX-32.1 7305
5 EXHIBIR 32.2 a2019q1ex322-xnextgen.htm EX-32.2 7382
11 mbx-20190331_g1.jpg GRAPHIC 132868
  Complete submission text file 0001659617-19-000069.txt   5434598

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbx-20190331.xsd EX-101.SCH 43420
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mbx-20190331_cal.xml EX-101.CAL 52032
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mbx-20190331_def.xml EX-101.DEF 202460
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbx-20190331_lab.xml EX-101.LAB 495889
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbx-20190331_pre.xml EX-101.PRE 331606
12 EXTRACTED XBRL INSTANCE DOCUMENT mbx-20190331_htm.xml XML 787178
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 19818345
SIC: 2834 Pharmaceutical Preparations